Document is current
Any future updates will be listed below
-
Authors
Suzuki, Kazuhito
Tsukada, Nobuhiro
Nishimura, Noriko
Nagata, Yasuyuki
Okazuka, Kiyoshi
Mishima, Yuko
Yokoyama, Masahiro
Nishiwaki, Kaichi
Ishida, Tadao
Yano, Shingo
Terui, Yasuhito
Suzuki, Kenshi
- License Information
-
More Information
Article History
Received: 4 June 2019
Revised: 17 October 2019
Accepted: 17 October 2019
First Online: 30 October 2019
Compliance with ethical standards
:
: K. Suzuki received personal fees from Takeda Pharmaceutical Company, Janssen Pharmaceutical K.K., Bristol-Myers Squibb, and Celgene, outside the submitted work; N. Tsukada received a personal fee from Takeda, outside the submitted work; N. Nishimura received personal fees from Takeda Pharmaceutical Company, Janssen Pharmaceutical K.K., and Chugai Pharmaceutical. Co., Ltd., outside the submitted work; Y. Mishima reports personal fees from Chugai Pharmaceutical. Co., Ltd., Roche group, outside the submitted work; M. Yokoyama received personal fees from Chugai Pharmaceutical. Co., Ltd., outside the submitted work; K. Nishiwaki reports grants from Novartis Pharma K.K., and grants and personal fees from Kyowa Hakko Kirin Co, Ltd, outside the submitted work; T. Ishida received personal fees from Janssen, Celgene, Ono Pharmaceuticals, Bristol-Myers Squibb, and Takeda, outside the submitted work. The other authors declare that they have no conflicts of interest.
Free to read: This content has been made available to all.
